Get the DPUK newsletter
Sign up to subscribe to the DPUK newsletter.
Keep up to date with all that's going on at Dementias Platform UK. There are around 4 newsletters a year, which include news about developments in our infrastructure services, studies, partnerships and collaborations.
Social Media
We're currently active on LinkedIn and X (Twitter) and post about every aspect of DPUK. Most of our news is posted here first including jobs, new studies, programme's milestones, information on training, seminars and conferences. On X, we are @DementiasUK, and on LinkedIn we are simply Dementias Platform UK
What's new
DPUK Research Reflections
7 November 2024
It's been ten years since Dementias Platform UK first launched back in the autumn of 2014. We hear from some of those who were there when it all started as they give their assessment of what's been accomplished.
A decade of DPUK research
4 November 2024
Dementias Platform UK is ten years old. We launched in 2014 and have over the decade built an infrastructure which has enabled wide-ranging research and brought together a collaborative community in dementia research. During the 2024 Clinical Trials on Alzheimer's Disease (CTAD) conference, Professor John Gallacher was reflecting on a decade of hard work by the large team past and present at DPUK.
The drugs do work but cost too much
24 October 2024
This week Donanemab, a second new treatment that slows the progression of Alzheimer’s disease has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) but deemed too expensive by the National Institute for Health and Care Excellence (NICE) for widespread use in the NHS. At the same time, DPUK gathered in Nottingham for the latest in our Great Minds events to consider, in the absence of and in addition to accessible treatments, how can you live well with dementia?
International Data Access
3 October 2024
DPUK is committed to internationalising access to datasets. Professor John Gallacher recently addressed a Summit in Washington DC about the high value of data sharing to advance dementia research.
The DPUK Data Portal gives researchers rapid, secure access to millions of health research records.
Our Trials Delivery Framework matches public volunteers to the right dementia studies.
Our Experimental Medicine Incubator accelerates and de-risks the development of new treatments.
Featured research: Can our genes predict our likelihood of developing dementia?
A project led by researchers at Cardiff University is analysing data in the DPUK Data Portal to predict genetic risk of dementia, focusing on genes related to the brain's immune system.
Featured Researcher
Yasir Widatalla
Research Assistant, SHINE
Yasir works as a Research Assistant for the SHINE project based in Cambridge, where he undertakes various responsibilities. These include identifying and reaching out to suitable patients and volunteers for study participation. He is also tasked with scheduling MRI, PET, and/or M/EEG imaging studies as well as applying behavioural tests and utilizing neurophysiological/imaging instruments both in clinic settings and during research study visits.
Yasir holds an MBBS degree from Sudan and was awarded the prestigious Chevening Scholarship to pursue Clinical Neuroscience at UCL during the academic year 22/23. His project at UCL focused on Electrophysiology and involved the study of EEG/calcium imaging.
Yasir is also a BNA scholar in 2024 (British Neuroscience Association). With a strong ambition to become a neurologist specializing in neurophysiology, Yasir demonstrates a keen interest in advancing his expertise in this field
Work with us
Would you like to increase the international visibility of your data? Try our Data Portal.
Do you need well-characterised volunteers for your early-phase trial? Use our Trials Delivery Framework.
Is there a mechanism you would like to investigate? Explore our Experimental Medicine Incubator.